Terms: = Leukemia AND CEP17
2 results:
1. "Immuno-flowFISH" for the Assessment of Cytogenetic Abnormalities in Chronic Lymphocytic leukemia.
Hui HYL; Clarke KM; Fuller KA; Stanley J; Chuah HH; Ng TF; Cheah C; McQuillan A; Erber WN
Cytometry A; 2019 May; 95(5):521-533. PubMed ID: 31016848
[TBL] [Abstract] [Full Text] [Related]
2. Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
Harris LN; Broadwater G; Abu-Khalaf M; Cowan D; Thor AD; Budman D; Cirrincione CT; Berry DA; Winer EP; Hudis CA; Hayes DF; Friedman P; Ellis M; Dressler L
J Clin Oncol; 2009 Jul; 27(21):3430-6. PubMed ID: 19470942
[TBL] [Abstract] [Full Text] [Related]
